---
$id: https://graph.org.ai/products/commodity/51151902
$type: Product
source: UNSPSC
code: "51151902"
title: "Chlorzoxazone"
class: "51151900"
classTitle: "Centrally acting skeletal muscle relaxants"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Chlorzoxazone

**UNSPSC Code**: 51151902
**Class**: [Centrally acting skeletal muscle relaxants](Centrally acting skeletal muscle relaxants.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C7H4ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0DE420U8G, chemically known as 2-benzoxazolinone, 5-chloro- but generally known as chlorzoxazone, which bears US NIH Compound Identifier 2733. European Medicines Agency schedules Chlorzoxazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06215MIG. The term CHLORZOXAZONE is an International Non-Proprietary Name. World Health Organization schedules chlorzoxazone in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORZOXAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorzoxazone under HS 29349990 and SITC 51579. As of Q4 2014, CHLORZOXAZONE remains the US FDA Preferred Term for this commodity. Chlorzoxazone bears US NLM identifiers UMLS ID C0008296 and NCI Concept Code C28926. SMILES: CLC1CC2[NH]C(=O)OC2CC1.

